The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections

Citation
Pc. Baker et al., The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections, ARCH PED AD, 155(2), 2001, pp. 135-139
Citations number
13
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
ISSN journal
10724710 → ACNP
Volume
155
Issue
2
Year of publication
2001
Pages
135 - 139
Database
ISI
SICI code
1072-4710(200102)155:2<135:TAOCTO>2.0.ZU;2-7
Abstract
Objective: To determine whether the addition of a single dose of ceftriaxon e sodium to a 10-day course of trimethoprim and sulfamethoxazole hastens ur ine sterilization or resolution of clinical symptoms in febrile children wi th urinary tract infections. Design: Prospective, single-blind, randomized study, Setting: Tertiary care children's hospital emergency department. Patients: Febrile children aged 6 months to 12 years with a presumptive uri nary tract infection based on history, physical examination, and urinalysis findings. Interventions: A history was taken, a physical examination and urinalysis a nd culture were performed, and a white blood cell count and erythrocyte sed imentation rate were obtained. Children were randomized to receive an intra muscular dose of ceftriaxone then 10 days of trimethoprim-sulfamethoxazole (IM+PO group) or oral trimethoprim-sulfamethoxazole alone (PO group). After receiving study medication, patients were discharged from the hospital to return in 48 hours for a follow-up evaluation and urine culture. Treatment failure was defined as the persistence of a positive culture at 48 hours or the need for hospital admission for intravenous rehydration or antibiotic therapy. Results: Sixty-nine children were enrolled, 34 in the IM+PO group and 35 in the PO group. The 2 groups were similar at the initial visit with respect to age, sex, clinical degrees of illness, white blood cell count, and eryth rocyte sedimentation rate (P>.05). At the 48-hour follow-up visit, there we re no differences between the 2 treatment groups in resolution of vomiting, fever, general appearance, abdominal tenderness, and hydration state (P>.0 5). There were 9 treatment failures, 4 in the IM+PO group and 35 in the PO group (P=.93). Conclusion: The addition of a single dose of intramuscular ceftriaxone to a 10-day course of oral trimethoprimsulfamethoxazole for urinary tract infec tion with fever resulted in no difference at 48 hours in the urine steriliz ation rate, degree of clinical improvement, or subsequent hospital admissio n rate.